IL126624A0 - 3-descladinose-2, 3-anhydroerythromycin derivatives - Google Patents

3-descladinose-2, 3-anhydroerythromycin derivatives

Info

Publication number: IL126624A0
Authority: IL; Israel
Prior art keywords: descladinose; anhydroerythromycin; derivatives; anhydroerythromycin derivatives
Prior art date: 1996-05-07

Application number

IL12662497A

Other languages

English (en)

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-07

Filing date

1997-04-25

Publication date

1999-08-17

1997-04-04 Priority claimed from US08/832,741 external-priority patent/US5750510A/en

1997-04-25 Application filed by Abbott Lab filed Critical Abbott Lab

1999-08-17 Publication of IL126624A0 publication Critical patent/IL126624A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL12662497A 1996-05-07 1997-04-25 3-descladinose-2, 3-anhydroerythromycin derivatives IL126624A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US64641896A	1996-05-07	1996-05-07
US08/832,741 US5750510A (en)	1997-04-04	1997-04-04	3-descladinose-2,3-anhydroerythromycin derivatives
PCT/US1997/007051 WO1997042205A1 (en)	1996-05-07	1997-04-25	3-descladinose-2,3-anhydroerythromycin derivatives

Publications (1)

Publication Number	Publication Date
IL126624A0 true IL126624A0 (en)	1999-08-17

Family

ID=27094927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12662497A IL126624A0 (en)	1996-05-07	1997-04-25	3-descladinose-2, 3-anhydroerythromycin derivatives

Country Status (16)

Country	Link
EP (1)	EP0922050B1 (cs)
JP (1)	JP2002502366A (cs)
KR (1)	KR20000011071A (cs)
AR (1)	AR007021A1 (cs)
AT (1)	ATE246199T1 (cs)
AU (1)	AU710532B2 (cs)
BR (1)	BR9708930A (cs)
CA (1)	CA2253451A1 (cs)
CZ (1)	CZ349698A3 (cs)
DE (1)	DE69723848T2 (cs)
DK (1)	DK0922050T3 (cs)
ES (1)	ES2203800T3 (cs)
IL (1)	IL126624A0 (cs)
NZ (1)	NZ332321A (cs)
PT (1)	PT922050E (cs)
WO (1)	WO1997042205A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2757518B1 (fr) *	1996-12-23	1999-06-11	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998051696A1 (en) *	1997-05-09	1998-11-19	Pfizer Products Inc.	Erythromycin derivatives
MXPA00009619A (es)	1998-04-02	2006-03-09	Targacept Inc	Composiciones farmaceuticas y metodos de uso.
FR2781484B1 (fr) *	1998-07-21	2001-08-10	Hoechst Marion Roussel Inc	Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
US20010031771A1 (en)	1999-05-24	2001-10-18	Gary Maurice Dull	Pharmaceutical compositions and methods for use
CA2451391A1 (en) *	2001-07-03	2003-01-16	Chiron Corporation	C12 modified erythromycin macrolides and ketolides having antibacterial activity
GB0225384D0 (en) *	2002-10-31	2002-12-11	Glaxo Group Ltd	Novel compounds
US6720308B1 (en)	2002-11-07	2004-04-13	Enanta Pharmaceuticals, Inc.	Anhydrolide derivatives having antibacterial activity
ES2278319T3 (es) *	2003-05-13	2007-08-01	Glaxo Group Limited	Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310992D0 (en) *	2003-05-13	2003-06-18	Glaxo Group Ltd	Novel compounds
GB0310984D0 (en) *	2003-05-13	2003-06-18	Glaxo Group Ltd	Novel compounds
GB0310980D0 (en) *	2003-05-13	2003-06-18	Glaxo Group Ltd	Novel compounds
GB0310986D0 (en) *	2003-05-13	2003-06-18	Glaxo Group Ltd	Novel compounds
US6765016B1 (en)	2003-06-05	2004-07-20	Enanta Pharmaceuticals, Inc.	Bicyclic ketolide derivatives
US6716820B1 (en)	2003-06-05	2004-04-06	Enanta Pharmaceuticals, Inc.	6-O-substituted bicyclic macrolides
US6790835B1 (en)	2003-06-05	2004-09-14	Enanta Pharmaceuticals, Inc.	Bicyclic macrolide derivatives
US6774115B1 (en)	2003-06-05	2004-08-10	Enanta Pharmaceuticals, Inc.	6-O-substituted bicyclic ketolides
US7414030B2 (en)	2004-01-07	2008-08-19	Enanta Pharmaceuticals, Inc.	6-11 Bicyclic erythromycin derivatives
WO2009106419A1 (en)	2008-02-08	2009-09-03	Basilea Pharmaceutica Ag	New macrolides and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2718450B1 (fr) *	1994-04-08	1997-01-10	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

1997
- 1997-04-25 AU AU27453/97A patent/AU710532B2/en not_active Ceased
- 1997-04-25 ES ES97921411T patent/ES2203800T3/es not_active Expired - Lifetime
- 1997-04-25 DE DE69723848T patent/DE69723848T2/de not_active Expired - Fee Related
- 1997-04-25 JP JP53996797A patent/JP2002502366A/ja not_active Withdrawn
- 1997-04-25 AT AT97921411T patent/ATE246199T1/de not_active IP Right Cessation
- 1997-04-25 KR KR1019980709226A patent/KR20000011071A/ko not_active Withdrawn
- 1997-04-25 BR BR9708930A patent/BR9708930A/pt unknown
- 1997-04-25 CA CA002253451A patent/CA2253451A1/en not_active Abandoned
- 1997-04-25 DK DK97921411T patent/DK0922050T3/da active
- 1997-04-25 EP EP97921411A patent/EP0922050B1/en not_active Expired - Lifetime
- 1997-04-25 IL IL12662497A patent/IL126624A0/xx unknown
- 1997-04-25 WO PCT/US1997/007051 patent/WO1997042205A1/en not_active Ceased
- 1997-04-25 CZ CZ983496A patent/CZ349698A3/cs unknown
- 1997-04-25 PT PT97921411T patent/PT922050E/pt unknown
- 1997-04-25 NZ NZ332321A patent/NZ332321A/xx unknown
- 1997-05-06 AR ARP970101877A patent/AR007021A1/es unknown

Also Published As

Publication number	Publication date
DK0922050T3 (da)	2003-11-24
EP0922050A1 (en)	1999-06-16
JP2002502366A (ja)	2002-01-22
CA2253451A1 (en)	1997-11-13
DE69723848D1 (en)	2003-09-04
ATE246199T1 (de)	2003-08-15
AU710532B2 (en)	1999-09-23
AR007021A1 (es)	1999-10-13
CZ349698A3 (cs)	1999-04-14
AU2745397A (en)	1997-11-26
NZ332321A (en)	2000-04-28
ES2203800T3 (es)	2004-04-16
PT922050E (pt)	2003-12-31
EP0922050B1 (en)	2003-07-30
BR9708930A (pt)	1999-08-03
WO1997042205A1 (en)	1997-11-13
KR20000011071A (ko)	2000-02-25
DE69723848T2 (de)	2004-07-01

Publication	Publication Date	Title
ZA97521B (en)	1997-08-04	19-Nor-pregnene derivatives.
IL127566A0 (en)	1999-10-28	Substituted 6,5-hetero- bicyclic derivatives
IL128049A0 (en)	1999-11-30	Substituted 6,6-hetero-bicyclic derivatives
HRP970174B1 (en)	2002-06-30	6-phenylpyridil-2-amine derivatives
AP9701156A0 (en)	1998-01-31	6-phenylpyridyl-2-amine derivatives
HU9700126D0 (en)	1997-02-28	2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives
IL126624A0 (en)	1999-08-17	3-descladinose-2, 3-anhydroerythromycin derivatives
HUP9902993A3 (en)	2002-01-28	Alkylaminobenzothiazole and -benzoxazole derivatives
HUP9701835A3 (en)	2001-04-28	Vinyl-pirrolidinone-cephalosporin derivatives
ZA974953B (en)	1997-12-08	Substituted pyrazolylpyrazole derivatives.
IL129418A0 (en)	2000-02-17	2-Methoxyphenylpiperazine derivatives
ZA979725B (en)	1998-05-22	Benzoaxozole derivative.
ZA982436B (en)	1999-09-23	Thiazolimine derivatives.
IL125149A0 (en)	1999-01-26	Pyrazol-4-yl-hetaroyl derivatives
HU9701479D0 (en)	1997-10-28	N-benzylazolium derivatives
GB9604996D0 (en)	1996-05-08	Benzodiazonine derivatives
ZA971167B (en)	1997-08-25	Heterocyclyl-ergoline derivatives.
CY2322B1 (en)	2003-11-14	Benzoaeguequinoline derivatives.
GB9600063D0 (en)	1996-03-06	Guaridine derivatives
SG70589A1 (en)	2000-02-22	1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
IL130283A0 (en)	2000-06-01	Polysaccharide-peptide derivatives
GB9702049D0 (en)	1997-03-19	Tetrahhydroisoquinoline derivatives
IL125974A0 (en)	1999-04-11	2-thioxotetrahydropyrimidin-4-one derivatives
ZA981307B (en)	1999-08-17	4-aminoethoxyindazole derivatives.
HU9601036D0 (en)	1996-06-28	Aryl-sulfonyl-hydroxamic-acid derivatives